** = Publikationen gelistet in SCI/SSCI/Pubmed
** Ficheux, AS; Brenaut, E; Schut, C; Dalgard, FJ; Bewley, A; van, Middendorp, H; Gieler, U; Lien, L; Sampogna, F; Ständer, S; Tomas-Aragones, L; Vulink, N; Finlay, AY; Legat, FJ; Titeca, G; Jemec, GB; Szabó, C; Grivcheva-Panovska, V; Spillekom-van, Koulil, S; Balieva, F; Szepietowski, JC; Reich, A; Ferreira, BR; Lvov, A; Romanov, D; Marron, SE; Gracia-Cazaña, T; Svensson, Å; Altunay, IK; Thompson, AR; Zeidler, C; Kupfer, J; Misery, L
Predictors of perceived stress, perceived stigmatization, and body dysmorphia in patients with chronic prurigo/prurigo nodularis: Results from an observational cross-sectional multicenter European study in 17 countries.
J Am Acad Dermatol. 2025;
Doi: 10.1016/j.jaad.2024.12.043
Web of Science
PubMed
FullText
FullText_MUG
** Giménez-Arnau, AM; Pinter, A; Sondermann, W; Reguiai, Z; Woolf, R; Lynde, C; Legat, FJ; Costanzo, A; Silvestre, JF; Mellerup, N; Østerdal, ML; Plohberger, U; Ryttig, L; Bauer, A, , trial, investigators
Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial.
Lancet. 2025;
Doi: 10.1016/S0140-6736(25)00001-7
PubMed
FullText
FullText_MUG
** Himmelstoss, IK; Legat, FJ; Gruber-Wackernagel, A; Wolf, P; Hofer, A
Phototherapy of granuloma annulare: a single center retrospective study.
Photochem Photobiol Sci. 2025;
Doi: 10.1007/s43630-025-00716-9
Web of Science
PubMed
FullText
FullText_MUG
** Patra, V; Woltsche, N; Bordag, N; Cerpes, U; Bokanovic, D; Repelnig, M; Clement, Y; Perchthaler, I; Köfeler, H; Fischl, M; Legat, F; Wedrich, A; Horwath-Winter, J; Ayciriex, S; Wolf, P
Metabolomic and Lipidomic Alterations in Patients with Atopic Dermatitis with Dupilumab-Associated Ocular Surface Disease.
JID Innov. 2025; 5(3):100361
Doi: 10.1016/j.xjidi.2025.100361
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Schratter, H; Graier, T; Legat, F; Hofmann-Wellenhof, R; Wolf, P
Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis.
Acta Derm Venereol. 2025; 105:adv42177
Doi: 10.2340/actadv.v105.42177
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Marron, SE; Gracia-Cazaña, T; Sampogna, F; Schut, C; Kupfer, J; Dalgard, FJ; Bewley, A; van, Beugen, S; Gieler, U; Lien, L; Ständer, S; Vulink, N; Finlay, AY; Legat, FJ; Titeca, G; Jemec, GB; Misery, L; Szabo, C; Grivcheva-Panovska, V; Spillekom-van, Koulil, S; Balieva, F; Szepietowski, JC; Reich, A; Roque, Ferreira, B; Lvov, A; Romanov, D; Svensson, A; Altunay, IK; Thompson, AR; Zeidler, C; Tomas-Aragones, L, , ESDAP, Study, Collaborators
Stigmatization and perceived health status in patients with hidradenitis suppurativa: an observational multicenter study in Europe.
Int J Dermatol. 2024;
Doi: 10.1111/ijd.17569
Web of Science
PubMed
FullText
FullText_MUG
** Patra, V; Woltsche, N; Cerpes, U; Bokanovic, D; Repelnig, M; Joshi, A; Perchthaler, I; Fischl, M; Vocanson, M; Bordag, N; Durdevic, M; Woltsche, J; Quehenberger, F; Legat, F; Wedrich, A; Horwath-Winter, J; Wolf, P
Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab-Associated Conjunctivitis in Patients with Atopic Dermatitis.
Ophthalmol Sci. 2024; 4(1): 100340
Doi: 10.1016/j.xops.2023.100340
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sampogna, F; Samela, T; Abeni, D; Schut, C; Kupfer, J; Bewley, AP; Finlay, AY; Gieler, U; Thompson, AR; Gracia-Cazaña, T; Balieva, F; Ferreira, BR; Jemec, GB; Lien, L; Misery, L; Marron, SE; Ständer, S; Zeidler, C; Szabó, C; Szepietowski, JC; Reich, A; Svensson, A; Altunay, IK; Legat, FJ; Grivcheva-Panovska, V; Romanov, DV; Lvov, AN; Titeca, G; Vulink, NC; Tomás-Aragones, L; van, Beugen, S; Evers, AWM; Dalgard, FJ, , European, Society, for, Dermatology, and, Psychiatry, (ESDaP), Study, collaborators
A cross-sectional study on gender differences in body dysmorphic concerns in patients with skin conditions in relation to sociodemographic, clinical and psychological variables.
J Eur Acad Dermatol Venereol. 2024;
Doi: 10.1111/jdv.20247
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Silverberg, JI; Wollenberg, A; Reich, A; Thaçi, D; Legat, FJ; Papp, KA; Stein, Gold, L; Bouaziz, JD; Pink, AE; Carrascosa, JM; Rewerska, B; Szepietowski, JC; Krasowska, D; Havlíčková, B; Kalowska, M; Magnolo, N; Pauser, S; Nami, N; Sauder, MB; Jain, V; Padlewska, K; Cheong, SY; Fleuranceau, Morel, P; Ulianov, L; Piketty, C, , ARCADIA, 1, and, ARCADIA, 2, Study, Investigators
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.
Lancet. 2024; 404(10451):445-460
Doi: 10.1016/S0140-6736(24)01203-0
Web of Science
PubMed
FullText
FullText_MUG
** Ständer, S; Pereira, MP; Zeidler, C; Legat, FJ; Misery, L; Lönndahl, L; Bewley, AP; Brenaut, E; Bobko, S; Elberling, J; Evers, AWM; Garcovich, S; Gieler, U; Gonçalo, M; Kupfer, J; Lambert, J; Lvov, A; Metz, M; Michenko, A; Papadavid, E; Reich, A; Savk, E; Schneider, G; Schut, C; Serra-Baldrich, E; Ständer, HF; Szepietowski, JC; Wallengren, J; Weisshaar, E; Augustin, M
EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions.
J Eur Acad Dermatol Venereol. 2024;
Doi: 10.1111/jdv.20102
Web of Science
PubMed
FullText
FullText_MUG
** Ständer, S; Yosipovitch, G; Legat, FJ; Reich, A; Paul, C; Simon, D; Naldi, L; Metz, M; Tsianakas, A; Pink, A; Fage, S; Micali, G; Weisshaar, E; Sundaram, H; Metelitsa, A; Augustin, M; Wollenberg, A; Homey, B; Fargnoli, MC; Sofen, H; Korman, NJ; Skov, L; Chen, X; Jabbar-Lopez, ZK; Piketty, C; Kwatra, SG, , OLYMPIA, 1, Investigators
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
JAMA Dermatol. 2024;
Doi: 10.1001/jamadermatol.2024.4796
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Weisshaar, E; Kupfer, JP; Bentz, P; Staubach-Renz, P; Legat, F; Kremer, AE; Ständer, H; Streit, M; Darsow, U; Mettang, T; Ständer, S
Validation of the German Pruritus Questionnaire for the systematic assessment of chronic pruritus.
J Dtsch Dermatol Ges. 2024;
Doi: 10.1111/ddg.15430
Web of Science
PubMed
FullText
FullText_MUG
** Yosipovitch, G; Lio, P; Legat, FJ; Chovatiya, R; Deleuran, M; Pierce, E; Casillas, M; Ding, Y; Yang, FE; Bardolet, L; Ständer, S
Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks.
Dermatol Ther (Heidelb). 2024;
Doi: 10.1007/s13555-024-01225-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Yosipovitch, G; Lio, PA; Rosmarin, D; Serra-Baldrich, E; Legat, FJ; Casillas, M; Pierce, E; Liu, Z; Sun, L; Elmaraghy, H; Ständer, S
Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials.
Br J Dermatol. 2024; 190(2): 289-291.
Doi: 10.1093/bjd/ljad435
Web of Science
PubMed
FullText
FullText_MUG
** Zeidler, C; Kupfer, J; Dalgard, FJ; Bewley, A; Evers, AWM; Gieler, U; Lien, L; Sampogna, F; Tomas, Aragones, L; Vulink, N; Finlay, AY; Legat, FJ; Titeca, G; Jemec, GB; Misery, L; Szabó, C; Grivcheva, Panovska, V; Spillekom, van, Koulil, S; Balieva, F; Szepietowski, JC; Reich, A; Ferreira, BR; Lvov, A; Romanov, D; Marron, SE; Gracia, Cazaña, T; Elyas, A; Altunay, IK; Thompson, AR; van, Beugen, S; Ständer, S; Schut, C
Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: Results from a European multi-centre study.
J Eur Acad Dermatol Venereol. 2024;
Doi: 10.1111/jdv.19913
Web of Science
PubMed
FullText
FullText_MUG
** Ziehfreund, S; Wecker, H; Mittag, S; Weis, J; Tizek, L; Verkhoturova, V; Legat, FJ; Weger, W; Grossschädl, K; Cerpes, U; Sadoghi, B; Riegler, M; Balato, A; Di Brizzi, EV; Buononato, D; Babino, G; Calzavara-Pinton, P; Rossi, MT; Rovaris, S; Dimech, A; Boffa, MJ; Chernyshov, P; Svyatenko, T; Kolodzinska, L; Sikora, M; Torres, T; Manolache, L; Scala, E; Biedermann, T; Zink, A
Happiness across the borders-A cross-sectional study among patients with psoriasis and atopic dermatitis in Europe
J EUR ACAD DERMATOL. 2024;
Doi: 10.1111/jdv.20288
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pereira, MP; Gutsche, A; Weisshaar, E; Halvorsen, JA; Wallengren, J; Legat, FJ; Garcovich, S; Savk, E; Reich, A; Bozek, A; Lvov, A; Bobko, S; Metz, M; Streit, M; Misery, L; Brenaut, E; Serra-Baldrich, E; Goncalo, M; Szepietowski, JC; Augustin, M; Zeidler, C; Ständer, S
Chronic nodular prurigo: Association between comorbidities, itch and quality of life.
J Eur Acad Dermatol Venereol. 2024;
Doi: 10.1111/jdv.20038
Web of Science
PubMed
FullText
FullText_MUG
** Schratter, H; Teufelberger, A; Vieyra-Garcia, P; Perchthaler, I; Fink-Puches, R; Gruber-Wackernagel, A; Hofer, A; Legat, F; Cerroni, L; Woltsche, J; Wolf, P
TCR Vβ repertoire analysis and immunophenotyping to detect target molecules in patients with mycosis fungoides and Se′zary syndrome
EUR J CANCER. 2024; 211(S2):S81-S81.-EORTC-CLTG Annual Meeting; OCT 9-11, 2024; Lausanne, SWITZERLAND.
Doi: 10.1016/j.ejca.2024.114495
[Poster]
Web of Science
FullText
FullText_MUG
** Silverberg, JI; Stein-Gold, L; Thaçi, D; Pink, AE; Papp, KA; Legat, FJ; Laquer, VT; Cheong, SY; Ulianov, L; Ryzhkova, A; Piketty, C
Nemolizumab elicits fast itch response in atopic dermatitis within 2 days: a post hoc analysis of ARCADIA 1 and 2 data
BRIT J DERMATOL. 2024; 191: 111-112.
Doi: 10.1093/bjd/ljae266.106
[Poster]
Web of Science
FullText
FullText_MUG
** Silverberg, JI; Wollenberg, A; Legat, FJ; Laquer, VT; Armstrong, AW; Herranz, P; Naldi, L; Ahmad, F; Ulianov, L; Piketty, C
Maintenance of efficacy and safety with nemolizumab at week 48: results from two global phase 3 pivotal studies (ARCADIA-1 and ARCADIA-2) in patients with moderate-to-severe atopic dermatitis
BRIT J DERMATOL. 2024; 191:
Doi: 10.1093/bjd/ljae266.041
[Poster]
Web of Science
FullText
FullText_MUG
** Silverberg, JI; Wollenberg, A; Legat, FJ; Laquer, VT; Ulianov, L; Cheong, SY; Ryzhkova, A; Piketty, C
Improvements in itch and sleep disturbance are maintained up to week 48 with nemolizumab plus TCS/TCI treatment in patients with moderate-to-severe atopic dermatitis: results from two global phase 3 pivotal studies (ARCADIA 1 and ARCADIA 2)
BRIT J DERMATOL. 2024; 191:
Doi: 10.1093/bjd/ljae266.042
[Poster]
Web of Science
FullText
FullText_MUG
** Woltsche, J; Teufelberger, AR; Vieyra-Garcia, P; Perchthaler, I; Fink-Puches, R; Gruber-Wackernagel, A; Hofer, A; Legat, F; Cerroni, L; Wolf, P
Identification of clones by TCR Vβ repertoire analysis supports diagnosis of leukemic cutaneous T-cell lymphoma
EUR J CANCER. 2024; 211: S24-S24.
Doi: 10.1016/j.ejca.2024.114388
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Yosipovitch, G; Lio, PA; Rosmarin, D; Casillas, M; Yang, FE; Hu, CR; Pierce, E; Legat, FJ; Carrascosa, JM; Crane, H; Boncompte, L; Stander, S
497-Lebrikizumab in combination with topical corticosteroids maintains improvements in itch and sleep at 68 weeks in patients with moderate-to-severe atopic dermatitis
BRIT J DERMATOL. 2024; 190: II6-II7.
Doi: 10.1093/bjd/ljad498.008
[Poster]
Web of Science
FullText
FullText_MUG
** Graier, T; Salmhofer, W; Jonak, C; Weger, W; Zikeli, C; Gruber, B; Sator, P; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Sassmann, C; Painsi, C; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Inzinger, M; Bangert, C; Ellersdorfer, C; Falkensteiner, K; Sadoghi, B; Gruber-Wackernagel, A; Hofer, A; Legat, F; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hötzenecker, W; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P
Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004-2022.
J Dtsch Dermatol Ges. 2023; 21(12): 1513-1523.
Doi: 10.1111/ddg.15213
Web of Science
PubMed
FullText
FullText_MUG
** Graier, T; Salmhofer, W; Jonak, C; Weger, W; Zikeli, C; Gruber, B; Sator, P; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Sassmann, C; Painsi, C; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Inzinger, M; Bangert, C; Ellersdorfer, C; Falkensteiner, K; Sadoghi, B; Gruber-Wackernagel, A; Hofer, A; Legat, F; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hötzenecker, W; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P
Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika-Therapie bei Patienten des Österreichischen Psoriasis-Registers von 2004 bis 2022.
J Dtsch Dermatol Ges. 2023; 21(12): 1513-1523.
Doi: 10.1111/ddg.15213_g
Web of Science
PubMed
FullText
FullText_MUG
** Kupsa, R; Gruber-Wackernagel, A; Hofer, A; Quehenberger, F; Wolf, P; Legat, FJ
Narrowband-ultraviolet B vs Broadband-ultraviolet B in Treatment of Chronic Pruritus: A Randomized, Single-blinded, Non-inferiority Study.
ACTA DERM-VENEREOL. 2023; 103: adv9403
Doi: 10.2340/actadv.v103.9403
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kwatra, SG; Yosipovitch, G; Legat, FJ; Reich, A; Paul, C; Simon, D; Naldi, L; Lynde, C; De, Bruin-Weller, MS; Nahm, WK; Sauder, M; Gharib, R; Barbarot, S; Szepietowski, JC; Conrad, C; Fleischer, A; Laquer, VT; Misery, L; Serra-Baldrich, E; Lapeere, H; Ahmad, F; Jabbar, Lopez, ZK; Piketty, C; Ständer, S, , OLYMPIA, 2, Investigators
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
N Engl J Med. 2023; 389(17): 1579-1589.
Doi: 10.1056/NEJMoa2301333
Web of Science
PubMed
FullText
FullText_MUG
** Van, Beugen, S; Schut, C; Kupfer, J; Bewley, AP; Finlay, AY; Gieler, U; Thompson, AR; Gracia-Cazaña, T; Balieva, F; Ferreira, BR; Jemec, GB; Lien, L; Misery, L; Marron, SE; Ständer, S; Zeidler, C; Szabó, C; Szepietowski, JC; Reich, A; Elyas, A; Altunay, IK; Legat, FJ; Grivcheva-Panovska, V; Romanov, DV; Lvov, AN; Titeca, G; Sampogna, F; Vulink, NC; Tomás-Aragones, L; Evers, AWM; Dalgard, FJ, , European, Society, for, Dermatology, and, Psychiatry, (ESDaP), Study, collaborators
Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries.
ACTA DERM-VENEREOL. 2023; 103: adv6485
Doi: 10.2340/actadv.v103.6485
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pereira, MP; Weisshaar, E; Halvorsen, JA; Wallengren, J; Legat, FJ; Garcovich, S; Savk, E; Reich, A; Bozek, A; Lvov, A; Bobko, S; Metz, M; Streit, M; Misery, L; Brenaut, E; Serra-Baldrich, E; Gonçalo, M; Szepietowski, JC; Augustin, M; Nau, T; Zeidler, C; Ständer, S
Chronic prurigo: Insufficient disease control in spite of high healthcare usage.
J EUR ACAD DERMATOL. 2023; 37(6): e808-e812.
Doi: 10.1111/jdv.18903
Web of Science
PubMed
FullText
FullText_MUG
** Augustin, M; Zeidler, C; von, Kiedrowski, R; Metz, M; Darsow, U; Raap, U; Legat, FJ; Sebastian, M; Weisshaar, E; Ständer, S
Indication for systemic therapy in chronic prurigo: Annotated checklist for practice.
J Dtsch Dermatol Ges. 2023;
Doi: 10.1111/ddg.15152
Web of Science
PubMed
FullText
FullText_MUG
** Augustin, M; Zeidler, C; von, Kiedrowski, R; Metz, M; Darsow, U; Raap, U; Legat, FJ; Sebastian, M; Weisshaar, E; Ständer, S
[Indikation zur Systemtherapie bei chronischer Prurigo: Kommentierte Checkliste für die Praxis].
J Dtsch Dermatol Ges. 2023; 21(7): 822-824.
Doi: 10.1111/ddg.15152_g
Web of Science
PubMed
FullText
FullText_MUG
** Kränke, T; Cerpes, U; Legat, F; Arbab, E; Kränke, B
[Recurrent livedo-like skin lesions following a vector-based COVID-19 vaccine].
Dermatologie (Heidelb). 2023; 74(8):614-617
Doi: 10.1007/s00105-023-05160-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stander, S; Yosipovitch, G; Legat, FJ; Reich, A; Paul, C; Simon, D; Naldi, L; Silverberg, JI; Gharib, R; Fleischer, A; Laquer, VT; Ahmad, F; Jabbar-Lopez, Z; Piketty, C; Kwatra, SG
Nemolizumab monotherapy was associated with significant improvements in prurigo activity score in adult patients with moderate-to-severe prurigo nodularis: results from a phase 3 trial (OLYMPIA 2)
BRIT J DERMATOL. 2023; 188: ljad162056
Doi: 10.1093/bjd/ljad162.056
[Poster]
Web of Science
FullText
FullText_MUG
** Yosipovitch, G; Lio, P; Rosmarin, D; Legat, F; Carrascosa, JM; Meskimen, E; Casillas, M; Pierce, E; Liu, ZQ; Zhong, JL; Ständer, S
Lebrikizumab improvement in itch reduction at 52 weeks in patients with moderate-to-severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials
J AM ACAD DERMATOL. 2023; 89(3):AB188-AB188.-Annual Meeting of the American-Academy-of-Dermatology (AAD); MAR 17-21, 2023; New Orleans, LA.
[Poster]
Web of Science
** Yosipovitch, G; Lio, PA; Rosmarin, D; Legat, FJ; Carrascosa, JM; Meskimen, E; Casillas, M; Pierce, E; Xu, CJ; Zhong, JL; Ständer, S
Lebrikizumab reduced interference of itch on sleep at 52 weeks in patients with moderate-to- severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials
J AM ACAD DERMATOL. 2023; 89(3):AB61-AB61.-Annual Meeting of the American-Academy-of-Dermatology (AAD); MAR 17-21, 2023; New Orleans, LA.
[Poster]
Web of Science
** Legat, FJ
Aquagenic pruritus indicates increased risks in patients with myeloproliferative neoplasms.
J Eur Acad Dermatol Venereol. 2023; 37(6):1095-1096
Doi: 10.1111/jdv.19107
Web of Science
PubMed
FullText
FullText_MUG
** Schut, C; Dalgard, FJ; Bewley, A; Evers, AWM; Gieler, U; Lien, L; Sampogna, F; Ständer, S; Tomás-Aragonés, L; Vulink, N; Finlay, AY; Legat, FJ; Titeca, G; Jemec, GB; Misery, L; Szabó, C; Grivcheva-Panovska, V; Spillekom-van, Koulil, S; Balieva, F; Szepietowski, JC; Reich, A; Roque, Ferreira, B; Lvov, A; Romanov, D; Marron, SE; Gracia-Cazaña, T; Svensson, A; Altunay, IK; Thompson, AR; Zeidler, C; Kupfer, J, , ESDAP, Study, collaborators
Body dysmorphia in common skin diseases: results of an observational, cross-sectional multicentre study among dermatological outpatients in 17 European countries.
Br J Dermatol. 2022; 187(1):115-125
Doi: 10.1111/bjd.21021
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ständer, S; Yosipovitch, G; Lacour, JP; Legat, FJ; Paul, C; Reich, A; Chaouche, K; Ahmad, F; Piketty, C
Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances.
J Eur Acad Dermatol Venereol. 2022; 36(10): 1820-1825.
Doi: 10.1111/jdv.18377
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ständer, S; Zeidler, C; Augustin, M; Darsow, U; Kremer, AE; Legat, FJ; Koschmieder, S; Kupfer, J; Mettang, T; Metz, M; Nast, A; Raap, U; Schneider, G; Ständer, H; Streit, M; Schut, C; Weisshaar, E
S2k Leitlinie: Diagnostik und Therapie des chronischen Pruritus.
J Dtsch Dermatol Ges. 2022; 20(10): 1386-1402.
Doi: 10.1111/ddg.14830_g
PubMed
FullText
FullText_MUG
** Ständer, S; Zeidler, C; Augustin, M; Darsow, U; Kremer, AE; Legat, FJ; Koschmieder, S; Kupfer, J; Mettang, T; Metz, M; Nast, A; Raap, U; Schneider, G; Ständer, H; Streit, M; Schut, C; Weisshaar, E
S2k guideline: Diagnosis and treatment of chronic pruritus.
J DTSCH DERMATOL GES. 2022; 20(10): 1387-1402.
Doi: 10.1111/ddg.14830
Web of Science
PubMed
FullText
FullText_MUG
** Weisshaar, E; Szepietowski, JC; Bernhard, JD; Hait, H; Legat, FJ; Nattkemper, L; Reich, A; Sadoghi, B; Sciascia, TR; Zeidler, C; Yosipovitch, G; Ständer, S
Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase.
J Eur Acad Dermatol Venereol. 2022; 36(3):453-461
Doi: 10.1111/jdv.17816
Web of Science
PubMed
FullText
FullText_MUG
** Stander, S; Yosipovitch, G; Lacour, JP; Legat, FJ; Paul, C; Reich, A; Chaouche, K; Ahmad, F; Winkleman, W; Piketty, C
Nemolizumab is associated with a rapid reduction of itch and sleep disturbance in patients with prurigo nodularis
J AM ACAD DERMATOL. 2022; 87(3): AB185-AB185.
[Poster]
Web of Science
** Curiel-Lewandrowski, C; Myrdal, CN; Saboda, K; Hu, C; Arzberger, E; Pellacani, G; Legat, FJ; Ulrich, M; Hochfellner, P; Oliviero, MC; Pasquali, P; Gill, M; Hofmann-Wellenhof, R
In Vivo Reflectance Confocal Microscopy as a Response Monitoring Tool for Actinic Keratoses Undergoing Cryotherapy and Photodynamic Therapy.
Cancers (Basel). 2021; 13(21):
Doi: 10.3390/cancers13215488
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Graier, T; Salmhofer, W; Jonak, C; Weger, W; Kölli, C; Gruber, B; Sator, PG; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Painsi, C; Selhofer, S; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Tanew, A; Inzinger, M; Tatarski, R; Bangert, C; Ellersdorfer, C; Lichem, R; Gruber-Wackernagel, A; Hofer, A; Legat, F; Schmiedberger, E; Strohal, R; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hoetzenecker, W; Trautinger, F; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.
Br J Dermatol. 2021; 184(6):1094-1105
Doi: 10.1111/bjd.19701
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Graier, T; Weger, W; Sator, PG; Salmhofer, W; Gruber, B; Jonak, C; Kölli, C; Schütz-Bergmayr, M; Vujic, I; Ratzinger, G; Häring, N; Painsi, C; Prillinger, K; Mlynek, A; Skvara, H; Trattner, H; Tanew, A; Lichem, R; Ellersdorfer, C; Legat, F; Gruber-Wackernagel, A; Hofer, A; Schmiedberger, E; Hoetzenecker, W; Müllegger, R; Saxinger, W; Quehenberger, F; Wolf, P
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis.
JAAD Int. 2021; 2: 62-75.
Doi: 10.1016/j.jdin.2020.10.012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gruber-Wackernagel, A; Schug, T; Graier, T; Legat, FJ; Rinner, H; Hofer, A; Quehenberger, F; Wolf, P
Long-Term Course of Polymorphic Light Eruption: A Registry Analysis.
FRONT MED-LAUSANNE. 2021; 8: 694281
Doi: 10.3389/fmed.2021.694281
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ
Itch in Atopic Dermatitis - What Is New?
FRONT MED-LAUSANNE. 2021; 8: 644760
Doi: 10.3389/fmed.2021.644760
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pereira, MP; Zeidler, C; Wallengren, J; Halvorsen, JA; Weisshaar, E; Garcovich, S; Misery, L; Brenaut, E; Şavk, E; Potekaev, N; Lvov, A; Bobko, S; Szepietowski, JC; Reich, A; Bozek, A; Legat, FJ; Metz, M; Streit, M; Serra-Baldrich, E; Gonçalo, M; Storck, M; Nau, T; Hoffmann, V; Steinke, S; Greiwe, I; Dugas, M; Augustin, M; Ständer, S
Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction.
Acta Derm Venereol. 2021; 101(2):adv00403-adv00403
Doi: 10.2340/00015555-3726
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pereira, MP; Ziehfreund, S; Rueth, M; Ewering, T; Legat, FJ; Lambert, J; Elberling, J; Misery, L; Brenaut, E; Papadavid, E; Garcovich, S; Evers, AWM; Halvorsen, JA; Szepietowski, JC; Reich, A; Gonçalo, M; Lvov, A; Bobko, S; Serra-Baldrich, E; Wallengren, J; Savk, E; Leslie, T; Ständer, S; Zink, A; EADV Task Force Pruritus
Google search trends for itch in Europe: a retrospective longitudinal study.
J Eur Acad Dermatol Venereol. 2021; 35(6):1362-1370
Doi: 10.1111/jdv.17077
Web of Science
PubMed
FullText
FullText_MUG
** Storck, M; Sandmann, S; Bruland, P; Pereira, MP; Steinke, S; Riepe, C; Soto-Rey, I; Garcovich, S; Augustin, M; Blome, C; Bobko, S; Legat, FJ; Potekaev, N; Lvov, A; Misery, L; Weger, W; Reich, A; Şavk, E; Streit, M; Serra-Baldrich, E; Szepietowski, JC; Dugas, M; Ständer, S; Zeidler, C
Pruritus Intensity Scales across Europe: a prospective validation study.
J Eur Acad Dermatol Venereol. 2021; 35(5):1176-1185
Doi: 10.1111/jdv.17111
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Cerpes, U; Repelnig, ML; Legat, FJ
Itch in Hymenoptera Sting Reactions.
Frontiers in Allergy. 2021; 2:
Doi: 10.3389/falgy.2021.727776
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schut, C; Dalgard, FJ; Bewley, A; Evers, AWM; Gieler, U; Lien, L; Sampogna, F; Stander, S; Tomas-Aragones, L; Vulink, N; Finlay, AY; Legat, FJ; Titeca, G; Jemec, GBE; Misery, L; Kemeny, L; Grivcheva-Panosvska, V; Koulil, SSV; Balieva, F; Szepietowski, JC; Reich, A; Ferreira, BR; Lvov, A; Romanov, D; Marron, SE; Gracia-Cazana, T; Svensson, A; Altunay, I; Thompson, A; Zeidler, C; Kupfer, J
Prevalence of symptoms of body dysmorphic disorder in patients with dermatological conditions compared to healthy skin controls: results of the ESDAP-study-II
BRIT J DERMATOL. 2021; 185(3):E81-E82.
[Poster]
Web of Science
** Graier, T; Fink-Puches, R; Porkert, S; Lang, R; Pöchlauer, S; Ratzinger, G; Tanew, A; Selhofer, S; Sator, PG; Hofer, A; Gruber-Wackernagel, A; Legat, FJ; Vieyra-Garcia, PA; Quehenberger, F; Wolf, P
Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it.
Front Med (Lausanne). 2020; 7:330-330
Doi: 10.3389/fmed.2020.00330
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pereira, MP; Hoffmann, V; Weisshaar, E; Wallengren, J; Halvorsen, JA; Garcovich, S; Misery, L; Brenaut, E; Savk, E; Potekaev, N; Lvov, A; Bobko, S; Szepietowski, JC; Reich, A; Bozek, A; Legat, FJ; Metz, M; Streit, M; Serra-Baldrich, E; Gonçalo, M; Storck, M; Greiwe, I; Nau, T; Steinke, S; Dugas, M; Ständer, S; Zeidler, C; EPP Consensus Conference Participants 2017
Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study.
J Eur Acad Dermatol Venereol. 2020; 34(10): 2373-2383.
Doi: 10.1111/jdv.16309
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ständer, S; Yosipovitch, G; Legat, FJ; Lacour, JP; Paul, C; Narbutt, J; Bieber, T; Misery, L; Wollenberg, A; Reich, A; Ahmad, F; Piketty, C
Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
N Engl J Med. 2020; 382(8): 706-716.
Doi: 10.1056/NEJMoa1908316
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Repelnig, ML; Weger, W; Cerpes, U; Wolf, P; Legat, FJ
Methyl aminolevulinate photodynamic therapy for Bowen's disease on the fingers-Is monotherapy sufficiently effective?
Photodermatol Photoimmunol Photomed. 2020; 36(6):487-489
Doi: 10.1111/phpp.12586
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wolf, P; Wiedenbauer, M; Graier, T; Benezeder, T; Gruber-Wackernagel, A; Legat, F; Hofer, A
Narrowband UVB (311nm) phototherapy maintains its high efficacy in psoriasis throughout repetitive treatment cycles.
J INVEST DERMATOL. 2020; 140(7):S86-S86.-Virtual Conference of the Society-for-Investigative-Dermatology (SID ); MAY 13-16, 2020; ELECTR NETWORK.
[Onlinepräsentation]
Web of Science
** Gruber-Wackernagel, A; Hofer, A; Legat, F; Wolf, P
Frequency of occurrence of polymorphic light eruption in patients treated with photohardening and patients treated with phototherapy for other diseases.
Photodermatol Photoimmunol Photomed. 2019; 35(2):100-105
Doi: 10.1111/phpp.12429
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ
Is there still a role for UV therapy in itch treatment?
Exp Dermatol. 2019; 28(12):1432-1438
Doi: 10.1111/exd.14011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Vieyra-Garcia, P; Fink-Puches, R; Porkert, S; Lang, R; Pöchlauer, S; Ratzinger, G; Tanew, A; Selhofer, S; Paul-Gunther, S; Hofer, A; Gruber-Wackernagel, A; Legat, F; Patra, V; Quehenberger, F; Cerroni, L; Clark, R; Wolf, P
Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial.
JAMA Dermatol. 2019; 155(5):538-547
Doi: 10.1001/jamadermatol.2018.5905
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zeidler, C; Steinke, S; Riepe, C; Bruland, P; Soto-Rey, I; Storck, M; Garcovich, S; Blome, C; Bobko, S; Legat, FJ; Potekaev, N; Lvov, A; Misery, L; Weger, W; Reich, A; Şavk, E; Streit, M; Serra-Baldrich, E; Szepietowski, JC; Yosipovitch, G; Chen, SC; Dugas, M; Ständer, S
Cross-European validation of the ItchyQoL in pruritic dermatoses.
J Eur Acad Dermatol Venereol. 2019; 33(2):391-397
Doi: 10.1111/jdv.15225
Web of Science
PubMed
FullText
FullText_MUG
** Pereira, MP; Zeidler, C; Nau, T; Bobko, S; Evers, AWM; Garcovich, S; Gonçalo, M; Halvorsen, JA; Lambert, J; Legat, FJ; Leslie, T; Metz, M; Misery, L; Nordlind, K; Reich, A; Schneider, G; Ständer, H; Streit, M; Szepietowski, JC; Wallengren, J; Weisshaar, E; Ständer, S; EADV Task Force Pruritus
Position Statement: Linear prurigo is a subtype of chronic prurigo.
J Eur Acad Dermatol Venereol. 2019; 33(2):263-266
Doi: 10.1111/jdv.15275
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ
The Antipruritic Effect of Phototherapy.
Front Med (Lausanne). 2018; 5(5):333-333
Doi: 10.3389/fmed.2018.00333
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pereira, MP; Steinke, S; Zeidler, C; Forner, C; Riepe, C; Augustin, M; Bobko, S; Dalgard, F; Elberling, J; Garcovich, S; Gieler, U; Gonçalo, M; Halvorsen, JA; Leslie, TA; Metz, M; Reich, A; Şavk, E; Schneider, G; Serra-Baldrich, E; Ständer, HF; Streit, M; Wallengren, J; Weller, K; Wollenberg, A; Bruland, P; Soto-Rey, I; Storck, M; Dugas, M; Weisshaar, E; Szepietowski, JC; Legat, FJ; Ständer, S; EADV Task Force Pruritus group members
European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo.
J Eur Acad Dermatol Venereol. 2018; 32(7):1059-1065
Doi: 10.1111/jdv.14570
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Steinke, S; Zeidler, C; Riepe, C; Bruland, P; Soto-Rey, I; Storck, M; Augustin, M; Bobko, S; Garcovich, S; Legat, FJ; Lvov, A; Misery, L; Osada, N; Reich, A; Şavk, E; Serra-Baldrich, E; Streit, M; Szepietowski, JC; Weger, W; Dugas, M; Ständer, S
Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial.
J Am Acad Dermatol. 2018; 79(3):457-463
Doi: 10.1016/j.jaad.2018.04.044
Web of Science
PubMed
FullText
FullText_MUG
** Wolf, P; Weger, W; Legat, F; Painsi, C; Saxinger, W; Müllegger, R; Sator, P; Ratzinger, G; Selhofer, S; Richter, L; Salmhofer, W; Lange-Asschenfeldt, B; Trautinger, F; Mlynek, A; Strohal, R; Augustin, M; Quehenberger, F
Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional survey.
J Dtsch Dermatol Ges. 2018; 16(8):981-990
Doi: 10.1111/ddg.13613
Web of Science
PubMed
FullText
FullText_MUG
** Wolf, P; Weger, W; Legat, F; Painsi, C; Saxinger, W; Müllegger, R; Sator, P; Ratzinger, G; Selhofer, S; Richter, L; Salmhofer, W; Lange-Asschenfeldt, B; Trautinger, F; Mlynek, A; Strohal, R; Augustin, M; Quehenberger, F
Lebensqualität und Behandlungsziele bei Psoriasis aus Patientensicht: Ergebnisse eines österreichweiten Querschnitt-Survey.
J Dtsch Dermatol Ges. 2018; 16(8):981-991
Doi: 10.1111/ddg.13613_g
PubMed
FullText
FullText_MUG
** Legat, FJ
[Importance of phototherapy in the treatment of chronic pruritus].
Hautarzt. 2018; 69(8):631-640
Doi: 10.1007/s00105-018-4229-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ständer, S; Legat, F
[Pruritus : Future research is to scratch before it starts itching].
HAUTARZT. 2018; 69(8): 618-619.
Doi: 10.1007/s00105-018-4225-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Vieyra-Garcia, P; Fink-Puches, R; Porkert, S; Lang, R; Pochlauer, S; Ratzinger, G; Tanew, A; Selhofer, S; Paul-Gunther, S; Hofer, A; Gruber-Wackernagel, A; Legat, F; Vijaykumar, P; Quehenberger, F; Cerroni, L; Clark, R; Wolf, P
Effectiveness of low-dose, low-frequency PUVA treatment and maintenance in early stage (IA-IIA) mycosis fungoides
EXP DERMATOL. 2018; 27: 46-46.-3rd Inflammatory Skin Disease Summit; DEC 12-15, 2018; Vienna, AUSTRIA.
[Poster]
Web of Science
** Ständer, S; Zeidler, C; Augustin, M; Bayer, G; Kremer, AE; Legat, FJ; Maisel, P; Mettang, T; Metz, M; Nast, A; Niemeier, V; Raap, U; Schneider, G; Ständer, HF; Staubach, P; Streit, M; Weisshaar, E
S2k-Leitlinie zur Diagnostik und Therapie des chronischen Pruritus - Update - Kurzversion.
J Dtsch Dermatol Ges. 2017; 15(8):860-873
Doi: 10.1111/ddg.13304_g
PubMed
FullText
FullText_MUG
** Ständer, S; Zeidler, C; Augustin, M; Bayer, G; Kremer, AE; Legat, FJ; Maisel, P; Mettang, T; Metz, M; Nast, A; Niemeier, V; Raap, U; Schneider, G; Ständer, HF; Staubach, P; Streit, M; Weisshaar, E
S2k Guidelines for the diagnosis and treatment of chronic pruritus - update - short version.
J Dtsch Dermatol Ges. 2017; 15(8):860-872
Doi: 10.1111/ddg.13304
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ; Gruber-Wackernagel, A; Hofer, A; Waltner, K; Wolf, P
Aprepitant, a NK1-antagonist, administered for 16 weeks reduced itch and supported resolution of skin lesions in a patient with chronic prurigo
J INVEST DERMATOL. 2017; 137(10):S204-S204.-47th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 27-30, 2017; Salzburg, AUSTRIA.
Doi: 10.1016/j.jid.2017.07.167
[Poster]
Web of Science
FullText
FullText_MUG
** Legat, FJ; Gruber-Wackernagel, A; Hofer, A; Waltner, K; Wolf, P
APREPITANT, A NK1-ANTAGONIST, ADMINISTERED FOR 16 WEEKS REDUCED ITCH AND SUPPORTED RESOLUTION OF SKIN LESIONS IN A PATIENT WITH CHRONIC PRURIGO
ACTA DERM-VENEREOL. 2017; 97(8):1028-1028.-9th World Congress on Itch 2017; OCT 15-17, 2017; Wroclaw, Poland.
[Oral Communication]
Web of Science
** Legat, FJ; Hofer, A; Gruber-Wackerna-Gel, A; Quehenberger, F; Waltner, K; Wolf, P
BOTH NARROWBAND-UVB AND BROADBAND-UVB ARE EQUALLY EFFECTIVE IN REDUCING ITCH IN CHRONIC PRURITUS PATIENTS
ACTA DERM-VENEREOL. 2017; 97(8):1056-1057.-9th World Congress on Itch; OCT 15-17; Wroclaw, Poland.
[Poster]
Web of Science
** Vieyra-Garcia, PA; Fink-Puches, R; Porkert, S; Lang, R; Pochlauer, S; Ratzinger, G; Tanew, A; Selhofer, S; Sator, P; Cerroni, L; Hofer, A; Gruber-Wackernagel, A; Legat, FJ; Wolf, P
PUVA induces a shift in systemic T-cell function and Treg activity in lesional skin of MF patients
J INVEST DERMATOL. 2017; 137(10):S293-S293.-47th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 27-30, 2017; Salzburg, AUSTRIA.
Doi: 10.1016/j.jid.2017.07.788
[Poster]
Web of Science
FullText
FullText_MUG
** Legat, FJ; Wolf, P
Daylight photodynamic therapy: where and when is it possible?
Br J Dermatol. 2017; 176(6):1440-1441
Doi: 10.1111/bjd.15541
Web of Science
PubMed
FullText
FullText_MUG
** Inzinger, M; Wippel-Slupetzky, K; Weger, W; Richter, L; Mlynek, A; Fleischander, B; Scheurecker, C; Sandor, N; Mairhofer, D; Sator, PG; Moser-Oberthaler, S; Häring, N; Viznerova, P; Painsi, C; Tanew, A; Ponholzer, P; Tatarski, R; Brenner, W; Stingl, G; Salmhofer, W; Rappersberger, K; Klein, G; Saxinger, W; Auböck, J; Kölli, C; Trautinger, F; Steiner, A; Ratzinger, G; Strohal, R; Riedl, E; Lange-Asschenfeldt, B; Pehamberger, H; Volc-Platzer, B; Selhofer, S; Legat, FJ; Müllegger, R; Reider, N; Schmuth, M; Hintner, H; Hofer, A; Gruber-Wackernagel, A; Aberer, W; Quehenberger, F; Wolf, P
Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria.
Acta Derm Venereol. 2016; 96(2):207-212
Doi: 10.2340/00015555-2214
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ständer, S; Zeidler, C; Riepe, C; Steinke, S; Fritz, F; Bruland, P; Soto-Rey, I; Storck, M; Agner, T; Augustin, M; Blome, C; Dalgard, F; Evers, AW; Garcovich, S; Gonçalo, M; Lambert, J; Legat, FJ; Leslie, T; Misery, L; Raap, U; Reich, A; Şavk, E; Streit, M; Serra-Baldrich, E; Szepietowski, J; Wallengren, J; Weisshaar, E; Dugas, M
European EADV network on assessment of severity and burden of Pruritus (PruNet): first meeting on outcome tools.
J Eur Acad Dermatol Venereol. 2016; 30(7):1144-1147
Doi: 10.1111/jdv.13296
Web of Science
PubMed
FullText
FullText_MUG
** Inzinger, M; Legat, FJ; Hofer, A; Weger, W; Gruber-Wackernagel, A; Salmhofer, W; Wolf, P
Short- to intermediate-term follow-up in patients treated with the combination of 311-nm ultraviolet B phototherapy and biological agents.
Br J Dermatol. 2014; 171(4):915-917
Doi: 10.1111/bjd.12992
Web of Science
PubMed
FullText
FullText_MUG
** Aigner, B; Legat, FJ; Schuster, C; El Shabrawi-Caelen, L
Sun-induced pustular dermatosis of the scalp - a new variant of erosive pustular dermatosis of the scalp?
Acta Derm Venereol. 2014; 94(4):457-458
Doi: 10.2340/00015555-1723
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Inzinger, M; Weger, W; Wippel-Slupetzky, K; Fleischanderl, B; Richter, L; Mlynek, A; Viznerova, P; Scheurecker, C; Sandor, N; Haring, N; Sator, P; Tatarski, R; Tanew, A; Painsi, C; Mairhofer, D; Moser-Oberthaler, S; Ponholzer, P; Brenner, W; Salmhofer, W; Stingl, G; Saxinger, W; Rappersberger, K; Klein, G; Riedl, E; Aubock, J; Kolli, C; Strohal, R; Steiner, A; Selhofer, S; Pehamberger, H; Lange-Asschenfeldt, B; Trautinger, F; Reider, N; Vloc-Platzer, B; Legat, FJ; Mullegger, R; Hintner, H; Ratzinger, G; Schmuth, M; Hofer, A; Gruber-Wackernagel, A; Aberer, W; Quehenberger, F; Wolf, P
Drug adherence to ustekinumab in the treatment of plaque psoriasis under daily life conditions: report from the Psoriasis Registry Austria
BRIT J DERMATOL. . 2014; 171(6):E168-E168.-7th International Congress of Psoriasis - From Gene to Clinic; DEC 11-13, 2014; London, ENGLAND.
[Poster]
Web of Science
** Vieyra-Garcia, P; Mayer, G; Pressl, H; Reginato, E; Schweintzger, N; Bambach, I; Legat, F; Hofer, A; Gruber-Wackernagel, A; Cerroni, L; Fink-Puches, R; Wolf, P
Higher frequencies but impaired suppressive capacity of regulatory T cells after PUVA in cutaneous T-cell lymphoma
EXP DERMATOL. 2014; 23: 12-12.-Inflammatory Skin Disease Summit - The Translational Revolution; NOV 19-21, 2014; Vienna, AUSTRIA.
[Poster]
Web of Science
** Tilz, H; Becker, JC; Legat, F; Schettini, AP; Inzinger, M; Massone, C
Allopurinol in the treatment of acquired reactive perforating collagenosis.
An Bras Dermatol. 2013; 88(1):94-97
Doi: 10.1590/s0365-05962013000100012
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aigner, B; Legat, F; El-Shabrawi, L;
Sun-triggered pustulosis of the scalp - a new variant of erosive pustular dermatosis of the scalp?.
J DTSCH DERMATOL GES. 2013; 11: 15-16.
[Oral Communication]
Web of Science
** Curiel-Lewandrowski, C; Legat, FL; Pellacani, G; Arzberger, E; Hofer, A; Gruber-Wachkernagel, A; Hoiman-Wellenhof, R;
Reflectance confocal microscopy for the monitoring of actinic keratoses undergoing photodynamic therapy.
J INVEST DERMATOL. 2013; 133: S179-S179.-International Investigative Dermatology Meeting; MAY 08-11, 2013; Edinburgh, SCOTLAND.
[Poster]
Web of Science
** Bodenlenz, M; Höfferer, C; Magnes, C; Schaller-Ammann, R; Schaupp, L; Feichtner, F; Ratzer, M; Pickl, K; Sinner, F; Wutte, A; Korsatko, S; Köhler, G; Legat, FJ; Benfeldt, EM; Wright, AM; Neddermann, D; Jung, T; Pieber, TR
Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling.
Eur J Pharm Biopharm. 2012; 81(3):635-641
Doi: 10.1016/j.ejpb.2012.04.009
Web of Science
PubMed
FullText
FullText_MUG
** Bretterklieber, A; Legat, FJ; Wolf, P; Hofer, A
Retrospective long-term follow-up in patients with chronic palmoplantar dermatoses after good response to bath PUVA therapy.
J Dtsch Dermatol Ges. 2012; 10(11):814-818
Doi: 10.1111/j.1610-0387.2012.07975.x
Web of Science
PubMed
FullText
FullText_MUG
** Wolf, P; Weger, W; Legat, FJ; Posch-Fabian, T; Gruber-Wackernagel, A; Inzinger, M; Salmhofer, W; Hofer, A
Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial.
Br J Dermatol. 2012; 166(1):147-153
Doi: 10.1111/j.1365-2133.2011.10616.x
Web of Science
PubMed
FullText
FullText_MUG
** Gruber-Wackernagel, A; Bambach, I; Legat, FJ; Hofer, A; Byrne, SN; Quehenberger, F; Wolf, P
Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1,25-dihydroxyvitamin D₃ analogue in polymorphic light eruption.
Br J Dermatol. 2011; 165(1):152-163
Doi: 10.1111/j.1365-2133.2011.10333.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Gruber-Wackernagel, A; Heinemann, A; Konya, V; Byrne, SN; Singh, TP; Hofer, A; Legat, F; Wolf, P
Photohardening restores the impaired neutrophil responsiveness to chemoattractants leukotriene B4 and formyl-methionyl-leucyl-phenylalanin in patients with polymorphic light eruption.
Exp Dermatol. 2011; 20(6):473-476
Doi: 10.1111/j.1600-0625.2011.01264.x
Web of Science
PubMed
FullText
FullText_MUG
** Hofer, A; Legat, FJ; Gruber-Wackernagel, A; Quehenberger, F; Wolf, P
Topical liposomal DNA-repair enzymes in polymorphic light eruption.
Photochem Photobiol Sci. 2011; 10(7):1118-1128
Doi: 10.1039/c1pp05009e
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Inzinger, M; Heschl, B; Weger, W; Hofer, A; Legat, FJ; Gruber-Wackernagel, A; Tilz, H; Salmhofer, W; Quehenberger, F; Wolf, P
Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
Br J Dermatol. 2011; 165(3):640-645
Doi: 10.1111/j.1365-2133.2011.10396.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Wolf, P; Hofer, A; Weger, W; Posch-Fabian, T; Gruber-Wackernagel, A; Legat, FJ
311 nm ultraviolet B-accelerated response of psoriatic lesions in adalimumab-treated patients.
Photodermatol Photoimmunol Photomed. 2011; 27(4):186-189
Doi: 10.1111/j.1600-0781.2011.00594.x
Web of Science
PubMed
FullText
FullText_MUG
** Gruber-Wackernagel, A; Rinner, B; Griesbacher, A; Groselj-Strele A; Hofer, A; Legat, FJ; Stauber, R; Byrne, SN; Wolf, P
Phototherapeutic hardening modulates systemic baseline cytokine levels in PLE patients
Journal of Investigative Dermatology. 2011; 131(2):S105-S105.-41st Annual ESDR Meeting; SEP 7-9; 2011; Barcelona, Spain.
[Poster]
Web of Science
** Inzinger, M; Heschl, B; Weger, W; Gruber-Wackernagel, A; Legat, FJ; Hofer, A; Kokol, R; Tilz, H; Salmhofer, W; Quehenberger, F; Wolf, P
Efficacy of methotrexate versus fumaric acid esters administered under daily life conditions in moderate to severe chronic plaque psoriasis
J INVEST DERMATOL. 2011; 131: S45-S45.-41st Annual Meeting of the European-Society-for-Dermatological-Research; SEP 07-10, 2011; Barcelona, SPAIN.
Web of Science
** Bretterklieber, A; Legat, F; Gruber-Wackernagel, A; Wolf, P; Hofer, A
Long-term results in patients with recalcitrant dermatoses of palms and soles after bath PUVA therapy
J INVEST DERMATOL. 2010; 130: S64-S64.
[Poster]
Web of Science
** Gruber-Wackernagel, A; Bambach, I; Legat, FJ; Hofer, A; Byrne, SN; Quehenberger, F; Wolf, P
Calcipotriol cream as a prophylactic treatment for polymorphic light eruption
J INVEST DERMATOL. 2010; 130: S44-S44.
[Oral Communication]
Web of Science
** Heinemann, A; Gruber-Wackernagel, A; Konya, V; Byrne, SN; Singh, TP; Legat, FJ; Hofer, A; Wolf, P
Photohardening restores the impaired neutrophil responsiveness to chemoattractants in patients with polymorphic light eruption
J INVEST DERMATOL. 2010; 130: S48-S48.
[Oral Communication]
Web of Science
** Inzinger, M; Heschl, B; Weger, W; Hofer, A; Legat, F; Gruber-Wackernagel, A; Salmhofer, W; Wolf, P
Efficacy of PUVA therapy compared with biologics in moderate to severe chronic plaque psoriasis
J Invest Dermatol. JID 2010; Abstracts from the 40th Annual Meeting of the European Society for Dermatological Research.2010; 130: S55-S55.-40th Annual Meeting of the European Society for Dermatological Research
; Sep 8-11, 2010; Helsinki, FINLAND.
[Oral Communication]
Web of Science
** Legat, FI; Gruber-Wackernagel, A; Obermayer-Pietsch, B; Byrne, SN; Wehr, E; Hofer, A; Wolf, P
Patients with polymorphic light eruption have decreased levels of serum 25-hydroxy vitamin D: epiphenomenon or pathogenic factor?
J INVEST DERMATOL. 2010; 130: S48-S48.
[Poster]
Web of Science
** Weger, W; Hofer, A; Legat, FJ; Posch-Fabian, T; Gruber-Wackernagel, A; Inzinger, M; Salmhofer, W; Wolf, P
UVB-311nm advances the clearance of psoriatic lesions in ustekinumab-treated patients
J INVEST DERMATOL. 2010; 130: S48-S48.
[Poster]
Web of Science
** Wiesinger, D; Gruber-Wackernagel, A; Legat, F; Wolf, P; Hofer, A
Evaluation of the long-term efficacy of UVB-311nm-therapy in vitiligo patients
J INVEST DERMATOL. 2010; 130: S100-S100.
[Poster]
Web of Science
** Wolf, P; Gruber-Wackernagel, A; Legat, F; Hofer, A; Bambach, I; Mayer, G; Absenger, M; Frohlich, E; Byrne, S
Successful phototherapy of polymorphic light eruption patients is associated with a recruitment of mast cells into the skin
J INVEST DERMATOL. 2010; 130: S48-S48.
[Oral Communication]
Web of Science
** Wolf, P; Hofer, A; Legat, FJ; Bretterklieber, A; Weger, W; Salmhofer, W; Kerl, H
Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept.
Br J Dermatol. 2009; 160(1):186-189
Doi: 10.1111/j.1365-2133.2008.08926.x
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ; Wolf, P
Cutaneous sensory nerves: mediators of phototherapeutic effects?
Front Biosci (Landmark Ed). 2009; 14(6):4921-4931
Doi: 10.2741/3577
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ; Sepic, G; Quehenberger, F; Armstong, CA; Ansel, JC; Wang, M; Class, JD; Wolf, P
Chronic UV-exposure induces significant changes of the cutaneous neurosensory system in mice
NEUROPEPTIDES. 2009; 43(5):442-442.-Neuropeptide Festival 2009; JUL 20-23, 2009; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Legat, FJ; Sepic, G; Quehenberger, F; Wang, M; Glass, JD; Armstong, CA; Ansel, JC; Wolf, P
Chronic UV-Exposure Induces Significant Changes Of The Cutaneous Neurosensory System In Mice
J INVEST DERMATOL. 2009; 129: S32-S32.
[Poster]
Web of Science
** Legat, FJ; Quehenberger, F; Wolf, P
The role of narrowband UV-B plus alefacept combination therapy in the treatment of psoriasis - Reply
ARCH DERMATOL. 2008; 144(8): 1068-1069.
Doi: 10.1001/archderm.144.8.1068
Web of Science
FullText
FullText_MUG
Google Scholar
** Legat, FJ; Hofer, A; Wackernagel, A; Salmhofer, W; Quehenberger, F; Kerl, H; Wolf, P
Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis
ARCH DERMATOL. 2007; 143(8): 1016-1022.
Doi: 10.1001/archderm.143.8.1016
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Wackernagel, A; Legat, FJ; Hofer, A; Quehenberger, F; Kerl, H; Wolf, P
Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus.
Photodermatol Photoimmunol Photomed. 2007; 23(1):15-19
Doi: 10.1111/j.1600-0781.2007.00261.x
Web of Science
PubMed
FullText
FullText_MUG
** Hofer, A; Kopera, D; Legat, FJ; Kerl, H; Wolf, P
Concomitant treatment of chronic plaque psoriasis with initial pulsed dye laser and narrow-band UV-B therapy
J INVEST DERMATOL. 2007; 127: S27-S27.-37. Annual Meeting - European Society for Dermatological Research; Sep 5-8, 2007; Zurich, Switzerland.
[Poster]
Web of Science
** Legat, FJ; Bretterklieber, A; Haar, M; Sepic, G; Hofer, A; Wackernagel, A; Quehenberger, F; Kerl, H; Wolf, P
The effect of topical capsaicin pretreatment on the induction of polymorphous light eruption (PLE) by solar simulated light
J INVEST DERMATOL. 2007; 127: S44-S44.-37th Annual European Society for Dermatological Reasearch Meeting; SEPT 6-8, 2007; Zürich, Switzerland.
[Poster]
Web of Science
** Sepic, G; Wolf, P; Legat, FJ; Leinweber, B; Kerl, H
Non-melanoma skin cancer and skin innervation: a correlation?
. 2007; 127(2s): S95-S95.
[Poster]
Web of Science
** Hofer, A; Hassan, AS; Legat, FJ; Kerl, H; Wolf, P
The efficacy of excimer laser (308 nm) for vitiligo at different body sites.
J Eur Acad Dermatol Venereol. 2006; 20(5):558-564
Doi: 10.1111/j.1468-3083.2006.01547.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Holzer, A; Wolf, P; Legat, FJ; Kerl, H; Hofer, A
Successful thalidomide therapy for actinic prurigo in a European woman.
J Dtsch Dermatol Ges. 2006; 4(11):961-964
Doi: 10.1111/j.1610-0387.2006.06125.x
(- Case Report)
PubMed
FullText
FullText_MUG
** Wackernagel, A; Hofer, A; Legat, F; Kerl, H; Wolf, P
Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
Br J Dermatol. 2006; 154(3):519-523
Doi: 10.1111/j.1365-2133.2005.07008.x
Web of Science
PubMed
FullText
FullText_MUG
** Lassacher, A; Worda, M; Kaddu, S; Heitzer, E; Legat, F; Massone, C; Cerroni, L; Kerl, H; Ananthaswamy, HN; Wolf, P
T1799A BRAF mutation is common in PUVA lentigines.
J Invest Dermatol. 2006; 126(8):1915-1917
Doi: 10.1038/sj.jid.5700250
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Legat, FJ; Wolf, P
Photodamage to the cutaneous sensory nerves: role in photoaging and carcinogenesis of the skin?
Photochem Photobiol Sci. 2006; 5(2):170-176
Doi: 10.1039/b508856a
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ; Holzer, A; Wackernagel, A; Hofer, A; Quehenberger, F; Kerl, H; Wolf, P
Photodynamic therapy (PDT) with fractionated versus unfractionated illumination: A half-side comparison in patients with actinic keratoses
J INVEST DERMATOL. 126: 77-77.
[Poster]
Web of Science
** Legat, FJ; Wackernagel, A; Hofer, A; Quehenberger, F; Hoffmann, C; Kerl, H; Wolf, P
Hardening therapy in patients with Polymorphic Light Eruption: comparison between broadband and narrowband Ultraviolet B
J INVEST DERMATOL. 126: 140-140.
[Poster]
Web of Science
** Hofer, A; Hassan, AS; Legat, FJ; Kerl, H; Wolf, P
Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
Br J Dermatol. 2005; 152(5):981-985
Doi: 10.1111/j.1365-2133.2004.06321.x
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ; Krause, R; Zenahlik, P; Hoffmann, C; Scholz, S; Salmhofer, W; Tscherpel, J; Tscherpel, T; Kerl, H; Dittrich, P
Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.
Antimicrob Agents Chemother. 2005; 49(10):4368-4371
Doi: 10.1128/AAC.49.10.4368-4371.2005
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Stengel, D; Görzer, E; Schintler, M; Legat, FJ; Amann, W; Pieber, T; Ekkernkamp, A; Graninger, W
Second-line treatment of limb-threatening diabetic foot infections with intravenous fosfomycin.
J Chemother. 2005; 17(5):527-535
Doi: 10.1179/joc.2005.17.5.527
Web of Science
PubMed
FullText
FullText_MUG
** Hofer, A; Legat, FJ; Wackernagel, A; Kerl, H; Wolf, P
Topical DNA repair enzymes can prevent polymorphous light eruption
J INVEST DERMATOL. 2005; 125: A5-A5.-66th Annual Meeting of the Society-for-Investigative-Dermatology; MAY 04-07, 2005; St Louis, MO.
Web of Science
** Legat, FJ; Hofer, A; Wackernagel, A; Salmholer, W; Kerl, H; Wolf, P
Alefacept plus 311 nm narrowband ultraviolet B (NB-UVB) phototherapy in the treatment of psoriasis
J INVEST DERMATOL. 2005; 125: A4-A4.-66th Annual Meeting of the Society-for-Investigative-Dermatology; MAY 04-07, 2005; St Louis, MO.
Web of Science
** Legat, FJ; Hofer, A; Quehenberger, F; Kahofer, P; Kerl, H; Wolf, P
Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
J Am Acad Dermatol. 2004; 51(5):746-754
Doi: 10.1016/j.jaad.2004.04.029
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Legat, FJ; Jaiani, LT; Wolf, P; Wang, M; Lang, R; Abraham, T; Solomon, AR; Armstrong, CA; Glass, JD; Ansel, JC
The role of calcitonin gene-related peptide in cutaneous immunosuppression induced by repeated subinflammatory ultraviolet irradiation exposure.
Exp Dermatol. 2004; 13(4):242-250
Doi: 10.1111/j.0906-6705.2004.00185.x
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ; Wolf, P; Jaiani, LT; Lang, R; Wang, MS; Armstrong, CA; Ansel, JC; Glass, JD
Increased intraepidermal CGRP correlates with local immunosuppression after repeated broadband and narrowband UVB
EXP DERMATOL 2004 13: 585-585.
Web of Science
** Legat, FJ; Zalaudek, I; Grinschgl, S; Hofer, A; Kolm, I; Kerl, H; Wolf, P; Hofmann-Wellenhof, R
The effect of photochemotherapy (PUVA) on dermatoscopic features of melanocytic nevi
J INVEST DERMATOL 2004 123: 301-301.
Web of Science
** Horn, M; Wolf, P; Wulf, HC; Warloe, T; Fritsch, C; Rhodes, LE; Kaufmann, R; De Rie, M; Legat, FJ; Stender, IM; Solér, AM; Wennberg, AM; Wong, GA; Larkö, O
Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.
Br J Dermatol. 2003; 149(6):1242-1249
Doi: 10.1111/j.1365-2133.2003.05600.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Lang, R; Song, PI; Legat, FJ; Lavker, RM; Harten, B; Kalden, H; Grady, EF; Bunnett, NW; Armstrong, CA; Ansel, JC
Human corneal epithelial cells express functional PAR-1 and PAR-2.
Invest Ophthalmol Vis Sci. 2003; 44(1):99-105
Doi: 10.1167/iovs.02-0357
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ; Maier, A; Dittrich, P; Zenahlik, P; Kern, T; Nuhsbaumer, S; Frossard, M; Salmhofer, W; Kerl, H; Müller, M
Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome.
Antimicrob Agents Chemother. 2003; 47(1):371-374
Doi: 10.1128/AAC.47.1.371-374.2003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Legat, FJ; Hofer, A; Brabek, E; Quehenberger, F; Kerl, H; Wolf, P
Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis.
Arch Dermatol. 2003; 139(2):223-224
Doi: 10.1001/archderm.139.2.223
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Legat, FJ; Griesbacher, T; Schicho, R; Althuber, P; Schuligoi, R; Kerl, H; Wolf, P
Repeated subinflammatory ultraviolet B irradiation increases substance P and calcitonin gene-related peptide content and augments mustard oil-induced neurogenic inflammation in the skin of rats.
Neurosci Lett. 2002; 329(3):309-313
Doi: 10.1016/S0304-3940(02)00428-7
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Legat, FJ; Armstrong, CA; Ansel, JC
The cutaneous neurosensory system in skin disease.
Adv Dermatol. 2002; 18(2):91-109
PubMed
** Legat, FJ; Jaiani, LT; Wolf, P; Lang, R; Abraham, T; Armstrong, CA; Ansel, JC
Effects of experimental ultraviolet B-phototherapy on the cutaneous neurosensory system in hairless mice
J INVEST DERMATOL 2002 119: 330-330.
Web of Science
** Legat, FJ; Wolf, P; Kränke, B
Anaphylaxis to 5-methoxypsoralen during photochemotherapy.
Br J Dermatol. 2001; 145(5):821-822
Doi: 10.1046/j.1365-2133.2001.04464.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T; Legat, FJ
Effects of the non-peptide B2 receptor antagonist FR173657 in models of visceral and cutaneous inflammation.
Inflamm Res. 2000; 49(10):535-540
Doi: 10.1007/s000110050628
Web of Science
PubMed
FullText
FullText_MUG
** Hofmann-Wellenhof, R; Strunk, D; Wolf, P; Hubmer, M; Legat, F; Smolle, J; Kerl, H
UV-irradiation of human skin explants reduced migration of dendritic cells
J INVEST DERMATOL 2000 114: 227-227.
Web of Science
** Legat, FJ; Griesbacher, T; Althuber, P; Schuligoi, R; Kerl, H; Wolf, P
UVB irradiation with non-erythematogenic doses increases neuropeptides in the skin of rat ears.
PHOTOCHEM PHOTOBIOL 1999 69: 55S-55S.
Web of Science
** Legat, FJ; Griesbacher, T
The inflammatory response by a house dust mite extract in non-sensitized rats is caused by 5-hydroxytryptamine from mast cells.
J INVEST DERMATOL 1998 110: 652-652.
Web of Science
** Legat, FJ; Goessler, W; Schlagenhaufen, C; Soyer, HP
Argyria after short-contact acupuncture.
Lancet. 1998; 352(9123):241-241
Doi: 10.1016/S0140-6736(05)77851-X
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T; Legat, FJ
Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
Br J Pharmacol. 1997; 120(5):933-939
Doi: 10.1038/sj.bjp.0700966
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T; Sametz, W; Legat, FJ; Diethart, S; Hammer, S; Juan, H
Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Br J Pharmacol. 1997; 121(3):469-476
Doi: 10.1038/sj.bjp.0701159
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ; Althuber, P; Maier, R; Griesbacher, T; Lembeck, F
Evidence for the presence of NK1 and NK3 receptors on cholinergic neurones in the guinea-pig ileum.
Neurosci Lett. 1996; 207(2):125-128
Doi: 10.1016/0304-3940(96)12503-9
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Legat, FJ
FR173657, a new, potent and selective nonpeptide bradykinin antagonist: In vivo studies
NAUNYN-SCHMIED ARCH PHARMACOL 1996 354: 23-23.
Web of Science
** Griesbacher, T; Legat, FJ
The pharmacology of FR173657, a new, potent and selective non-peptide bradykinin antagonist: In vivo studies in rats and guinea-pigs
BRIT J PHARMACOL 1996 119: P309-P309.
Web of Science
** Legat, FJ; Sametz, W; Diethart, S; Hammer, S; Griesbacher, T
FR173657, a new, potent and selective nonpeptide bradykinin antagonist: In vitro studies
NAUNYN-SCHMIED ARCH PHARMACOL 1996 354: 24-24.
Web of Science
** Legat, FJ; Sametz, W; Diethart, S; Hammer, S; Griesbacher, T
The pharmacology of FR173657, a new, potent and selective non-peptide bradykinin antagonist: In vitro studies in guinea-pig, rat and rabbit tissues
BRIT J PHARMACOL 1996 119: P308-P308.
Web of Science
** Legat, FJ; Griesbacher, T; Lembeck, F
Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
Br J Pharmacol. 1994; 112(2):453-460
Doi: 10.1111/j.1476-5381.1994.tb13094.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Donnerer, J; Legat, FJ; Lembeck, F
CP-96,345, a non-peptide antagonist of substance P: II. Actions on substance P-induced hypotension and bronchoconstriction, and on depressor reflexes in mammals.
Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(3):323-327
Doi: 10.1007/BF00173546
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Legat, FJ; Griesbacher, T; Lembeck, F
CP-96,345, a non-peptide antagonist of substance P: I. Effects on the actions mediated by substance P and related tachykinins on the guinea-pig ileum and rabbit jejunum.
Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(3):315-322
Doi: 10.1007/BF00173545
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Lembeck, F; Griesbacher, T; Legat, FJ
Lack of significant unspecific effects of HOE 140 and other novel bradykinin antagonists in vitro and in vivo.
Agents Actions Suppl. 1992; 38 ( Pt 2)(3):414-422
PubMed
Google Scholar